News
The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
12h
MedPage Today on MSNFDA Approves Novavax COVID-19 Shot, but With Unusual RestrictionsNovavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
Gaithersburg’s Novavax has secured formal regulatory approval for its Covid vaccine. It's a major win, after the FDA delayed ...
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.
5h
Stocktwits on MSNNovavax Wins FDA Approval For COVID-19 Vaccine: Retail Calls For Buyback And Bigger MovesNovavax Inc. drew retail attention on Friday after receiving a Biologics License Application for its COVID-19 vaccine, ...
The Food and Drug Administration has granted full approval to Novavax, Inc. (NASDAQ:NVAX) COVID-19 vaccine, but with notable ...
The Food and Drug Administration has approved the Novavax COVID-19 vaccine—with strict conditions. Coming after four years of ...
The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results